Drug profile · INN
liotrix (t4
EUTHROID-2
liotrix (t4 (EUTHROID-2) is a thyroid hormone receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — liotrix (t4
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
liotrix (t4 (EUTHROID-2) is a thyroid hormone receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Thyroid hormone receptor agonist
Primary target: Thyroid hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is liotrix (t4?
liotrix (t4 (EUTHROID-2) is a thyroid hormone receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for liotrix (t4?
EUTHROID-2 is a marketed brand name for liotrix (t4. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of liotrix (t4?
liotrix (t4 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.